Biosimilars are an opportunity to help reduce the burden of rising treatment costs.

Diversity drives innovation, which in turn drives change and progress.

At Sandoz our work is focused on improving access to medicines, access to medical information and access ...

Sandoz announced a commitment of $10 million USD in medicines to Americares.

Explore Novartis

See our product listing, including: NDCs, Size, Dosage Forms and more.